CD1C and neoplasm: Specifically, CD1c+ mDCs and CD141+ mDCs can be activated by a distinct set of toll-like receptors (TLRs), and subsequently secrete large amounts of cytokines IFN-γ and IL-12 which allow the highly effective induction of CTLs and Th1 responses against tumor [11, 12].